title: Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy.
authors.affiliation: Programa de Trasplante Cardiaco, Hospital Juan Canalejo, A Coruña, Spain.
authors.forename: M G
authors.initials: MG
authors.lastname: Crespo-Leiro
authors.forename: M J
authors.initials: MJ
authors.lastname: Paniagua
authors.forename: I
authors.initials: I
authors.lastname: Mosquera
authors.forename: T
authors.initials: T
authors.lastname: Tabuyo
authors.forename: L
authors.initials: L
authors.lastname: De la Fuente
authors.forename: B
authors.initials: B
authors.lastname: Bouzas
authors.forename: J A
authors.initials: JA
authors.lastname: Rodriguez
authors.forename: L F
authors.initials: LF
authors.lastname: Hermida
authors.forename: A
authors.initials: A
authors.lastname: Juffé
authors.forename: A
authors.initials: A
authors.lastname: Castro-Beiras
mesh_terms: D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012449:Safety; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus